Outset Medical to Report Second Quarter 2023 Financial Results on Wednesday, August 2, 2023
13 Julho 2023 - 9:30AM
Business Wire
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced that it
will release financial results for the second quarter of 2023 after
the close of trading on Wednesday, August 2, 2023.
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time)
Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed,
Chief Financial Officer, will host a conference call to discuss
financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm
Eastern Time) on Wednesday, August 2, 2023. Those interested in
listening to the conference call may do so by registering online.
Once registered, participants will receive dial-in numbers and a
unique pin to join the call. Participants are encouraged to
register more than 15 minutes before the start of the call. A live
and archived webcast of the event will be available on the
“Investors” section of the Outset website at
https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo® Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230712374952/en/
Jim Mazzola Vice President, Investor Relations
jmazzola@outsetmedical.com
Brian Johnston Gilmartin Group investors@outsetmedical.com
Outset Medical (NASDAQ:OM)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Outset Medical (NASDAQ:OM)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024